Incyte to Report First Quarter Financial Results
Incyte (Nasdaq: INCY) has scheduled its first quarter 2025 financial results announcement for April 29, 2025. The company will release its Q1 2025 financial results via press release at 7:00 a.m. ET, followed by a conference call and webcast at 8:00 a.m. ET.
Investors can access the conference call through domestic (877-407-3042) and international (201-389-0864) dial-in numbers using conference ID 13753168. A replay will be available for 30 days, and the webcast with slides can be accessed at Investor.Incyte.com, remaining available for 90 days.
Incyte (Nasdaq: INCY) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 29 aprile 2025. L'azienda pubblicherà i risultati finanziari del Q1 2025 tramite comunicato stampa alle 7:00 ET, seguito da una conference call e un webcast alle 8:00 ET.
Gli investitori possono accedere alla conference call tramite i numeri di chiamata nazionali (877-407-3042) e internazionali (201-389-0864) utilizzando l'ID conferenza 13753168. Una registrazione sarà disponibile per 30 giorni e il webcast con le diapositive sarà accessibile su Investor.Incyte.com, rimanendo disponibile per 90 giorni.
Incyte (Nasdaq: INCY) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 29 de abril de 2025. La compañía publicará sus resultados financieros del Q1 2025 a través de un comunicado de prensa a las 7:00 a.m. ET, seguido de una conferencia telefónica y un webcast a las 8:00 a.m. ET.
Los inversores pueden acceder a la conferencia telefónica a través de los números de marcación nacionales (877-407-3042) e internacionales (201-389-0864) utilizando el ID de conferencia 13753168. Una grabación estará disponible durante 30 días, y el webcast con las diapositivas se podrá acceder en Investor.Incyte.com, permaneciendo disponible durante 90 días.
Incyte (Nasdaq: INCY)는 2025년 1분기 재무 결과 발표를 2025년 4월 29일로 예정했습니다. 회사는 2025년 1분기 재무 결과를 동부 표준시 기준 오전 7시에 보도자료를 통해 발표하며, 오전 8시에 컨퍼런스 콜과 웹캐스트가 진행됩니다.
투자자들은 국내 전화번호(877-407-3042)와 국제 전화번호(201-389-0864)를 통해 컨퍼런스 콜에 접속할 수 있으며, 컨퍼런스 ID 13753168을 사용해야 합니다. 재생은 30일 동안 제공되며, 슬라이드가 포함된 웹캐스트는 Investor.Incyte.com에서 접근할 수 있으며, 90일 동안 이용 가능합니다.
Incyte (Nasdaq: INCY) a prévu l'annonce de ses résultats financiers pour le premier trimestre 2025 le 29 avril 2025. La société publiera ses résultats financiers du T1 2025 via un communiqué de presse à 7h00 ET, suivi d'une conférence téléphonique et d'un webinaire à 8h00 ET.
Les investisseurs peuvent accéder à la conférence téléphonique via les numéros de composition nationaux (877-407-3042) et internationaux (201-389-0864) en utilisant l'ID de conférence 13753168. Un enregistrement sera disponible pendant 30 jours, et le webinaire avec les diapositives pourra être consulté sur Investor.Incyte.com, restant disponible pendant 90 jours.
Incyte (Nasdaq: INCY) hat die Bekanntgabe seiner finanziellen Ergebnisse für das erste Quartal 2025 auf den 29. April 2025 terminiert. Das Unternehmen wird die finanziellen Ergebnisse des Q1 2025 um 7:00 Uhr ET über eine Pressemitteilung veröffentlichen, gefolgt von einer Telefonkonferenz und einem Webcast um 8:00 Uhr ET.
Investoren können über die nationalen (877-407-3042) und internationalen (201-389-0864) Einwahlnummern auf die Telefonkonferenz zugreifen, indem sie die Konferenz-ID 13753168 verwenden. Eine Aufzeichnung wird 30 Tage lang verfügbar sein, und der Webcast mit Folien kann unter Investor.Incyte.com abgerufen werden und bleibt 90 Tage lang verfügbar.
- None.
- None.
The schedule for the press release and conference call/webcast is as follows:
- Q1 2025 Press Release: April 29, 2025 at 7:00 a.m. ET
- Q1 2025 Conference Call: April 29, 2025 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13753168
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250410696945/en/
Media
media@incyte.com
Investors
ir@incyte.com
Source: Incyte
FAQ
When will Incyte (INCY) release its Q1 2025 earnings?
What time is Incyte's (INCY) Q1 2025 earnings call?
How can investors access Incyte's (INCY) Q1 2025 earnings call?
How long will Incyte's (INCY) Q1 2025 earnings call replay be available?
